This invention provides chemical inhibitors of the activity of various phospholipase enzymes, particularly cytosolic phospholipase A.sub.2 enzymes (cPLA.sub.2), more particularly including inhibitors of cytosolic phospholipase A.sub.2 alpha enzymes (cPLA.sub.2.alpha.). In some embodiments, the inhibitors have the Formula I: ##STR00001## wherein the constituent variables are as defined herein.

 
Web www.patentalert.com

< N-oxides of N-phenyl-2-pyrimidine-amine derivatives

> Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptide

> 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis

~ 00532